This study aims to explore the association between MMP-11and clinical, radiological, and pathological features of breast cancer and evaluate its potential as a prognostic marker in early-stage, hormone receptor-positive breast cancer, acknowledging the evolving landscape of breast cancer management and surveillance tools. This evidence concerns the gene NR4A1 and breast cancer.